FAKTOR-OPTIONSSCHEIN - LABCORP HOLDINGS Stock

Certificat

DE000MG15L24

Real-time Bid/Ask 04:20:59 2024-06-26 EDT
6.37 EUR / 7.26 EUR +3.26% Intraday chart for FAKTOR-OPTIONSSCHEIN - LABCORP HOLDINGS
Current month+49.66%
1 month+20.88%
Date Price Change
24-06-25 6.6 +0.15%
24-06-24 6.59 +7.15%
24-06-21 6.15 -6.68%
24-06-20 6.59 +8.93%
24-06-19 6.05 -5.62%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 03:57 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying LABCORP HOLDINGS INC.
Issuer Morgan Stanley
WKN MG15L2
ISINDE000MG15L24
Date issued 2024-03-27
Strike 173.4 $
Maturity Unlimited
Parity 4.91 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.39
Lowest since issue 3.97
Spread 0.89
Spread %12.26%

Company Profile

Labcorp Holdings Inc. provides comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company serves clients in more than 100 countries.
Sector
-
More about the company

Ratings for Labcorp Holdings Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Labcorp Holdings Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
207.8 USD
Average target price
237.6 USD
Spread / Average Target
+14.32%
Consensus